Market Cap

AFT Pharmaceuticals Limited Market Capitalization:

A$307.4 Million

AUD as of July 1, 2024

US$204.7 Million

business AFT Pharmaceuticals Limited Company Profile

AFT Pharmaceuticals Limited Main Stock Listing

ASX: AFP

Market Capitalization History of AFT Pharmaceuticals Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of AFT Pharmaceuticals Limited market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$349.4 M -4.66%
Jan. 1, 2023 A$366.5 M -14.54%
Jan. 1, 2022 A$428.8 M -2.00%
Jan. 31, 2021 A$437.6 M -13.98%
Jan. 1, 2021 A$508.7 M 50.00%
Jan. 31, 2020 A$339.1 M 0.00%
Jan. 1, 2020 A$339.1 M 56.96%
Jan. 31, 2019 A$216.0 M 0.00%
Jan. 1, 2019 A$216.0 M -11.83%
Jan. 31, 2018 A$245.0 M 1.82%
Jan. 1, 2018 A$240.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

AFT Pharmaceuticals Limited Categories

New Zealand languages Healthcare languages Drug Manufacturers—Specialty & Generic
New Zealand Healthcare New Zealand Drug Manufacturers—Specialty & Generic

Stocks & Indices

AFT Pharmaceuticals Limited has the following listings and related stock indices.


Stock: ASX: AFP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.